Fabian Benjamin Christoffer Nordin
Nessuna posizione attualmente
Profilo
Fabian Benjamin Christoffer Nordin formerly worked at Biosergen AS, as Director, JP Nordiska AB, as Principal, Kaupthing Sverige AB, as Analyst, Kaupthing Bank A, as Principal, and Karolinska Development AB, as Investor & Media Relations Contact in 2013.
Mr. Nordin received his graduate degree from the University of Uppsala.
Precedenti posizioni note di Fabian Benjamin Christoffer Nordin
| Società | Posizione | Fine |
|---|---|---|
| Kaupthing Sverige AB | Analyst-Equity | - |
Kaupthing Bank A/S
 Kaupthing Bank A/S Major BanksFinance Kaupthing Bank A/S is an international bank. The company is based in Copenhagen, Denmark. Kaupthing Bank was acquired by Føroya Sparikassi from Kaupþing ehf on December 30, 2004. | Corporate Officer/Principal | - |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Direttore/Membro del Consiglio | - |
JP Nordiska AB
 JP Nordiska AB Investment Banks/BrokersFinance JP Nordiska AB provides investment banking services. The company also provides brokerage services. The company is headquartered in Stockholm, Sweden | Corporate Officer/Principal | - |
| KAROLINSKA DEVELOPMENT AB | Contatto Relazioni con gli Investitori | - |
Formazione di Fabian Benjamin Christoffer Nordin
| University of Uppsala | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| Aziende private | 4 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
JP Nordiska AB
JP Nordiska AB Investment Banks/BrokersFinance JP Nordiska AB provides investment banking services. The company also provides brokerage services. The company is headquartered in Stockholm, Sweden | Finance |
Kaupthing Bank A/S
Kaupthing Bank A/S Major BanksFinance Kaupthing Bank A/S is an international bank. The company is based in Copenhagen, Denmark. Kaupthing Bank was acquired by Føroya Sparikassi from Kaupþing ehf on December 30, 2004. | Finance |
| Kaupthing Sverige AB | Finance |
- Borsa valori
- Insiders
- Fabian Benjamin Christoffer Nordin
